Thermo Fisher Scientific Inc. (TMO) EV/EBIT Ratio: 27.94x
Is Thermo Fisher Scientific Inc.’s EV/EBIT ratio high or low?
Thermo Fisher Scientific Inc.'s EV/EBIT ratio of 27.94x is in line with its 5-year average of 28.30x, around the middle of its 5-year range (19.01x–36.01x).
The EV/EBIT ratio for Thermo Fisher Scientific Inc. (TMO) is 27.94x as of Tuesday, June 9, 2026. It is below its 12-month average by 1.10% (28.25x).
TMO EV/EBIT Ratio Chart
TMO Average EV/EBIT Ratio Chart
TMO Current vs Average EV/EBIT Ratio Chart
TMO EV/EBIT Ratio Metrics
EV/EBIT RATIO
27.94x
EV/EBIT RATIO AVG TTM
28.25x
EV/EBIT RATIO AVG 3Y
30.56x
EV/EBIT RATIO AVG 5Y
28.30x
EV/EBIT RATIO AVG 10Y
30.15x
EV/EBIT RATIO AVG 15Y
28.63x
EV/EBIT RATIO AVG 20Y
28.36x
CURRENT VS TTM AVG
-1.10%
CURRENT VS 3Y AVG
-8.58%
CURRENT VS 5Y AVG
-1.28%
CURRENT VS 10Y AVG
-7.32%
CURRENT VS 15Y AVG
-2.41%
CURRENT VS 20Y AVG
-1.47%
TMO Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | — | 27.94x | 28.25x | 30.56x | 28.30x |
| Amgen Inc. (AMGN) | $185.96B | 19.76x | 24.83x | 26.22x | 23.36x |
| Abbott Laboratories (ABT) | $158.94B | 22.76x | 28.03x | 30.34x | 27.87x |
| Gilead Sciences, Inc. (GILD) | $155.82B | 15.11x | 18.31x | 42.70x | 31.53x |
| Intuitive Surgical, Inc. (ISRG) | $151.09B | 47.00x | 63.37x | 73.05x | 67.80x |
| Pfizer Inc. (PFE) | $146.48B | 14.15x | 12.22x | 29.85x | 23.39x |
| Danaher Corporation (DHR) | $133.37B | 28.27x | 30.66x | 32.50x | 29.69x |
| CVS Health Corporation (CVS) | $123.84B | 32.34x | 28.81x | 19.87x | 18.74x |
| Bristol-Myers Squibb Company (BMY) | $115.34B | 12.08x | 11.36x | 15.42x | 18.93x |
| Vertex Pharmaceuticals Incorporated (VRTX) | $113.14B | 23.19x | 26.47x | 25.61x | 22.80x |
Thermo Fisher Scientific Inc. EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Thermo Fisher Scientific Inc. (TMO)?
- The EV/EBIT ratio for TMO stock is 27.94x.
- Is Thermo Fisher Scientific Inc.'s EV/EBIT ratio high or low?
- Thermo Fisher Scientific Inc.'s EV/EBIT ratio of 27.94x is in line with its 5-year average of 28.30x, around the middle of its 5-year range (19.01x–36.01x).
- What is the TTM average EV/EBIT ratio for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average EV/EBIT ratio for TMO stock is 28.25x.
- What is the 3Y average EV/EBIT ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average EV/EBIT ratio for TMO stock is 30.56x.
- What is the 5Y average EV/EBIT ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average EV/EBIT ratio for TMO stock is 28.30x.
- What is the 10Y average EV/EBIT ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average EV/EBIT ratio for TMO stock is 30.15x.
- What is the 15Y average EV/EBIT ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average EV/EBIT ratio for TMO stock is 28.63x.
- What is the 20Y average EV/EBIT ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average EV/EBIT ratio for TMO stock is 28.36x.
Thermo Fisher Scientific Inc. EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-09 | 27.94x |
| 2026-06-08 | 26.80x |
| 2026-06-05 | 26.95x |
| 2026-06-04 | 27.38x |
| 2026-06-03 | 27.00x |
| 2026-06-02 | 27.38x |
| 2026-06-01 | 27.94x |
| 2026-05-29 | 27.86x |
| 2026-05-28 | 27.62x |
| 2026-05-27 | 26.18x |
| 2026-05-26 | 25.80x |
| 2026-05-22 | 25.81x |
| 2026-05-21 | 25.86x |
| 2026-05-20 | 25.97x |
| 2026-05-19 | 25.79x |
| 2026-05-18 | 25.52x |
| 2026-05-15 | 25.35x |
| 2026-05-14 | 25.81x |
| 2026-05-13 | 25.70x |
| 2026-05-12 | 26.32x |
| 2026-05-11 | 26.01x |
| 2026-05-08 | 26.59x |
| 2026-05-07 | 27.03x |
| 2026-05-06 | 26.96x |
| 2026-05-05 | 26.67x |
| 2026-05-04 | 26.47x |
| 2026-05-01 | 26.78x |
| 2026-04-30 | 26.44x |
| 2026-04-29 | 25.84x |
| 2026-04-28 | 26.03x |
| 2026-04-27 | 25.92x |
| 2026-04-24 | 26.00x |
| 2026-04-23 | 25.86x |
| 2026-04-22 | 28.09x |
| 2026-04-21 | 28.59x |
| 2026-04-20 | 28.66x |
| 2026-04-17 | 28.68x |
| 2026-04-16 | 28.18x |
| 2026-04-15 | 28.92x |
| 2026-04-14 | 28.71x |
| 2026-04-13 | 28.10x |
| 2026-04-10 | 27.25x |
| 2026-04-09 | 27.45x |
| 2026-04-08 | 27.59x |
| 2026-04-07 | 26.94x |
| 2026-04-06 | 26.87x |
| 2026-04-02 | 27.03x |
| 2026-04-01 | 27.17x |
| 2026-03-31 | 27.03x |
| 2026-03-30 | 26.49x |
| 2026-03-27 | 26.18x |
| 2026-03-26 | 26.91x |
| 2026-03-25 | 27.00x |
| 2026-03-24 | 26.97x |
| 2026-03-23 | 26.40x |
| 2026-03-20 | 26.22x |
| 2026-03-19 | 26.03x |
| 2026-03-18 | 25.77x |
| 2026-03-17 | 26.14x |
| 2026-03-16 | 26.02x |
| 2026-03-13 | 25.75x |
| 2026-03-12 | 26.29x |
| 2026-03-11 | 27.23x |
| 2026-03-10 | 27.43x |
| 2026-03-09 | 27.90x |
| 2026-03-06 | 27.52x |
| 2026-03-05 | 28.32x |
| 2026-03-04 | 28.03x |
| 2026-03-03 | 27.81x |
| 2026-03-02 | 27.83x |
| 2026-02-27 | 28.42x |
| 2026-02-26 | 28.38x |
| 2026-02-25 | 28.60x |
| 2026-02-24 | 28.69x |
| 2026-02-23 | 28.73x |
| 2026-02-20 | 28.47x |
| 2026-02-19 | 28.67x |
| 2026-02-18 | 28.59x |
| 2026-02-17 | 28.02x |
| 2026-02-13 | 28.18x |
| 2026-02-12 | 28.41x |
| 2026-02-11 | 29.24x |
| 2026-02-10 | 29.84x |
| 2026-02-09 | 30.17x |
| 2026-02-06 | 29.98x |
| 2026-02-05 | 29.96x |
| 2026-02-04 | 31.04x |
| 2026-02-03 | 31.27x |
| 2026-02-02 | 31.83x |
| 2026-01-30 | 31.68x |
| 2026-01-29 | 32.32x |
| 2026-01-28 | 33.07x |
| 2026-01-27 | 33.83x |
| 2026-01-26 | 33.96x |
| 2026-01-23 | 33.93x |
| 2026-01-22 | 34.56x |
| 2026-01-21 | 34.42x |
| 2026-01-20 | 33.59x |
| 2026-01-16 | 33.58x |
| 2026-01-15 | 33.86x |
| 2026-01-14 | 33.73x |
| 2026-01-13 | 33.03x |
| 2026-01-12 | 33.43x |
| 2026-01-09 | 33.59x |
| 2026-01-08 | 33.00x |
| 2026-01-07 | 33.51x |
| 2026-01-06 | 33.68x |
| 2026-01-05 | 33.22x |
| 2026-01-02 | 32.34x |
| 2025-12-31 | 31.72x |
| 2025-12-30 | 31.91x |
| 2025-12-29 | 31.98x |
| 2025-12-26 | 31.78x |
| 2025-12-24 | 31.70x |
| 2025-12-23 | 31.74x |
| 2025-12-22 | 31.54x |
| 2025-12-19 | 31.17x |
| 2025-12-18 | 30.91x |
| 2025-12-17 | 30.92x |
| 2025-12-16 | 31.28x |
| 2025-12-15 | 31.55x |
| 2025-12-12 | 31.38x |
| 2025-12-11 | 31.69x |
| 2025-12-10 | 31.45x |
| 2025-12-09 | 30.94x |
| 2025-12-08 | 31.18x |
| 2025-12-05 | 31.40x |
| 2025-12-04 | 31.52x |
| 2025-12-03 | 31.77x |
| 2025-12-02 | 31.76x |
| 2025-12-01 | 31.99x |
| 2025-11-28 | 32.26x |
| 2025-11-26 | 32.37x |
| 2025-11-25 | 32.59x |
| 2025-11-24 | 32.03x |
| 2025-11-21 | 32.10x |
| 2025-11-20 | 31.40x |
| 2025-11-19 | 31.45x |
| 2025-11-18 | 31.56x |
| 2025-11-17 | 31.14x |
| 2025-11-14 | 31.68x |
| 2025-11-13 | 31.75x |
| 2025-11-12 | 32.12x |
| 2025-11-11 | 32.05x |
| 2025-11-10 | 31.57x |
| 2025-11-07 | 31.38x |
| 2025-11-06 | 31.08x |
| 2025-11-05 | 31.16x |
| 2025-11-04 | 31.04x |
| 2025-11-03 | 31.03x |
| 2025-10-31 | 31.15x |
| 2025-10-30 | 30.34x |
| 2025-10-29 | 30.44x |
| 2025-10-28 | 30.40x |
| 2025-10-27 | 30.70x |
| 2025-10-24 | 31.11x |
| 2025-10-23 | 31.08x |
| 2025-10-22 | 30.86x |
| 2025-10-21 | 30.42x |
| 2025-10-20 | 29.75x |
| 2025-10-17 | 29.51x |
| 2025-10-16 | 29.41x |
| 2025-10-15 | 28.99x |
| 2025-10-14 | 28.89x |
| 2025-10-13 | 28.83x |
| 2025-10-10 | 28.84x |
| 2025-10-09 | 29.31x |
| 2025-10-08 | 29.38x |
| 2025-10-07 | 29.52x |
| 2025-10-06 | 29.75x |
| 2025-10-03 | 29.72x |
| 2025-10-02 | 28.85x |
| 2025-10-01 | 29.12x |
| 2025-09-30 | 26.95x |
| 2025-09-29 | 25.85x |
| 2025-09-26 | 25.96x |
| 2025-09-25 | 25.72x |
| 2025-09-24 | 26.14x |
| 2025-09-23 | 26.22x |
| 2025-09-22 | 26.47x |
| 2025-09-19 | 26.69x |
| 2025-09-18 | 26.76x |
| 2025-09-17 | 26.36x |
| 2025-09-16 | 26.74x |
| 2025-09-15 | 26.44x |
| 2025-09-12 | 26.68x |
| 2025-09-11 | 27.25x |
| 2025-09-10 | 26.54x |
| 2025-09-09 | 26.82x |
| 2025-09-08 | 27.07x |
| 2025-09-05 | 27.31x |
| 2025-09-04 | 27.16x |
| 2025-09-03 | 26.92x |
| 2025-09-02 | 27.07x |
| 2025-08-29 | 27.31x |
| 2025-08-28 | 27.17x |
| 2025-08-27 | 27.09x |
| 2025-08-26 | 27.11x |
| 2025-08-25 | 27.22x |
| 2025-08-22 | 27.66x |
| 2025-08-21 | 26.89x |
| 2025-08-20 | 27.41x |
| 2025-08-19 | 27.58x |
| 2025-08-18 | 27.07x |
| 2025-08-15 | 27.14x |
| 2025-08-14 | 26.95x |
| 2025-08-13 | 26.94x |
| 2025-08-12 | 26.58x |
| 2025-08-11 | 25.87x |
| 2025-08-08 | 25.79x |
| 2025-08-07 | 25.51x |
| 2025-08-06 | 25.23x |
| 2025-08-05 | 26.06x |
| 2025-08-04 | 26.07x |
| 2025-08-01 | 25.90x |
| 2025-07-31 | 26.64x |
| 2025-07-30 | 27.11x |
| 2025-07-29 | 27.34x |
| 2025-07-28 | 27.48x |
| 2025-07-25 | 27.16x |
| 2025-07-24 | 27.00x |
| 2025-07-23 | 26.59x |
| 2025-07-22 | 24.69x |
| 2025-07-21 | 23.58x |
| 2025-07-18 | 24.06x |
| 2025-07-17 | 24.56x |
| 2025-07-16 | 24.14x |
| 2025-07-15 | 24.22x |
| 2025-07-14 | 24.58x |
| 2025-07-11 | 25.04x |
| 2025-07-10 | 24.84x |
| 2025-07-09 | 24.31x |
| 2025-07-08 | 24.62x |
| 2025-07-07 | 24.25x |
| 2025-07-03 | 24.77x |
| 2025-07-02 | 24.69x |
| 2025-07-01 | 24.39x |
| 2025-06-30 | 23.61x |
| 2025-06-27 | 23.75x |
| 2025-06-26 | 23.93x |
| 2025-06-25 | 23.86x |
| 2025-06-24 | 23.56x |
| 2025-06-23 | 23.35x |
| 2025-06-20 | 23.24x |
| 2025-06-18 | 22.98x |
| 2025-06-17 | 22.87x |
| 2025-06-16 | 23.59x |
| 2025-06-13 | 23.48x |
| 2025-06-12 | 24.09x |
| 2025-06-11 | 24.08x |
| 2025-06-10 | 24.05x |
| 2025-06-09 | 23.76x |
| 2025-06-06 | 23.44x |
| 2025-06-05 | 23.26x |
| 2025-06-04 | 23.52x |
| 2025-06-03 | 23.34x |
| 2025-06-02 | 23.17x |
| 2025-05-30 | 23.48x |
| 2025-05-29 | 23.53x |
| 2025-05-28 | 23.45x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper